|
| ||||||||||||
| ||||||||||||
|
Herz-Kreislauf
|
||||||||||||
|
| Sie befinden sich hier: Herz-Kreislauf | ||
|
2.1 Sympathomimetika | ||
|
2.2 Sympatholytika | ||
|
2.2.1 Alpha-Adrenorezeptorenblocker | ||
|
2.2.2 Beta-Adrenorezeptorenblocker | ||
|
2.3 Parasympathomimetika | ||
|
2.4 Parasympatholytika | ||
|
2.5 Antihypertensiva | ||
|
2.5.1 Vasodilatoren | ||
|
2.5.1.3 Diazoxid | ||
|
2.5.1.4 Nitroprussid-Natrium | ||
|
2.5.2 Calciumkanalblocker | ||
|
2.5.2.1 Dihydropyridine (Rudiment) | ||
|
2.5.2.2 Verapamil | ||
|
2.5.2.3 Diltiazem (Rudiment) | ||
|
2.5.3 Antisympathotonika | ||
|
2.5.3.1 Reserpin | ||
|
2.5.3.2 Guanethidin | ||
|
2.5.3.3 α-Methyl-Dopa | ||
|
2.5.3.4 Clonidin | ||
|
2.5.3.5 Moxonidin (Rudiment) | ||
|
2.5.3.6 Urapidil (Rudiment) | ||
|
2.5.4 Konversionshemmer (ACE-Hemmer) | ||
|
2.5.5 Angiotensin-II-Rezeptor-Antagonisten | ||
|
2.6 Antiarrhythmika | ||
|
2.7 Herzglykoside | ||
|
2.8 Methylxanthine | ||
|
2.9 Organische Nitrate | ||
|
2.10 Volumenersatzmittel | ||
|
2.11 Anämietherapie | ||
|
2.12 Antikoagulation und Fibrinolytika | ||
|
2.12.1 Heparin (Rudiment) | ||
|
2.12.3 Thrombozytenhemmer | ||
|
2.12.3.1 Glykoprotein IIb/IIIa-Antagonisten | ||
| Anzeige | ||
| ||||
|